Your browser doesn't support javascript.
loading
No difference in radiologic outcomes for natalizumab patients treated with extended interval dosing compared with standard interval dosing: Real-world evidence from MS PATHS.
Ryerson, Lana Zhovtis; Naismith, Robert T; Krupp, Lauren B; Charvet, Leigh E; Liao, Shirley; Fisher, Elizabeth; de Moor, Carl; Williams, James R; Campbell, Nolan.
Afiliação
  • Ryerson LZ; New York University Langone Multiple Sclerosis Comprehensive Care Center, 240 East 38th Street, New York, NY 10016, USA. Electronic address: lana.zhovtisryerson@nyulangone.org.
  • Naismith RT; Department of Neurology, Washington University, 660 S. Euclid Ave., St. Louis, MO 63110, USA.
  • Krupp LB; New York University Langone Multiple Sclerosis Comprehensive Care Center, 240 East 38th Street, New York, NY 10016, USA; Perlmutter Cancer Center at NYU Langone Huntington Medical Group, 789 Park Ave, Huntington, NY 11743, USA.
  • Charvet LE; New York University Langone Multiple Sclerosis Comprehensive Care Center, 240 East 38th Street, New York, NY 10016, USA.
  • Liao S; Biogen, 225 Binney St., Cambridge, MA 02142, USA, at the time of this analysis.
  • Fisher E; Biogen, 225 Binney St., Cambridge, MA 02142, USA.
  • de Moor C; Biogen, 225 Binney St., Cambridge, MA 02142, USA.
  • Williams JR; Biogen, 225 Binney St., Cambridge, MA 02142, USA.
  • Campbell N; Biogen, 225 Binney St., Cambridge, MA 02142, USA.
Mult Scler Relat Disord ; 58: 103480, 2022 Feb.
Article em En | MEDLINE | ID: mdl-35051898

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucoencefalopatia Multifocal Progressiva / Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucoencefalopatia Multifocal Progressiva / Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article